Chaoju Eye Care Holdings Limited reported a fresh share repurchase and provided an updated Next Day Disclosure Return to the Hong Kong Stock Exchange on 14 September 2026.

Key Takeaways

1. Issued Share Capital Unchanged • The company’s issued share base remains at 701.46 million ordinary shares. No new shares were issued and no treasury shares were cancelled as of 14 September 2026.

2. Latest On-Market Repurchase • On 14 September 2026, Chaoju Eye Care bought back 68,000 shares on the Exchange at prices between HKD 2.46 and HKD 2.50, spending a total of HKD 0.17 million. • These shares have been earmarked for cancellation.

3. Repurchases Pending Cancellation • Between 31 August and 14 September 2026 the company repurchased 1.85 million shares that have not yet been cancelled. This block represents approximately 0.26 % of the current issued share capital.

4. Status of 2026 Repurchase Mandate • Shareholders approved a mandate on 12 May 2026 authorising the repurchase of up to 70.52 million shares. • To date, 5.19 million shares, or 0.74 % of the shares outstanding on the mandate date, have been repurchased under this authority.

5. Moratorium on New Issues • In accordance with Hong Kong listing rules, Chaoju Eye Care is subject to a 30-day moratorium on issuing new shares following the latest buyback. The restriction extends to 14 October 2026.

All repurchase activities were authorised by the board and executed in compliance with Hong Kong listing requirements.